Russell J. Cox, EVP & Chief Commercial Officer at Jazz Pharmaceuticals plc (JAZZ), sold 500 shares at $177.82 ($89K) on 2015-08-11, disclosed to the SEC on 2015-08-12.
Scheduled sale ($89k) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| JAZZ | SELL | 2017-01-19 | $515K | — | Filing → |
| JAZZ | SELL | 2016-08-10 | $595K | — | Filing → |
| JAZZ | SELL | 2016-04-13 | $548K | — | Filing → |